EXCLUSIVE PATENT LICENSE AGREEMENTExclusive Patent License Agreement • August 4th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
This EXCLUSIVE PATENT LICENSE AGREEMENT (the “Agreement”), effective as of this 18th day of June, 2009 (the “Effective Date”), is entered into by and between Glycomed, Inc., a California corporation and a wholly owned subsidiary of Ligand Pharmaceuticals Incorporated (“Glycomed”), and ParinGenix, Inc., a Delaware corporation (“ParinGenix”).
